We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+24.45%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$416M
AUM Growth
+$86.4M
Cap. Flow
+$12M
Cap. Flow %
2.89%
Top 10 Hldgs %
20.32%
Holding
270
New
32
Increased
111
Reduced
38
Closed
36

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$5.82M
2
HUM icon
Humana
HUM
+$5.53M
3
DXCM icon
DexCom
DXCM
+$5.36M
4
LDOS icon
Leidos
LDOS
+$5.21M
5
CIEN icon
Ciena
CIEN
+$5.2M

Top Sells

Rank Stock Value
1
DOV icon
Dover
DOV
+$4.31M
2
RTN
Raytheon Company
RTN
+$3.93M
3
XYL icon
Xylem
XYL
+$3.92M
4
NVR icon
NVR
NVR
+$3.84M
5
NSC icon
Norfolk Southern
NSC
+$3.82M

Sector Composition

Rank Sector Weight
1 Technology 30.93%
2 Healthcare 18.12%
3 Industrials 9.94%
4 Financials 7.57%
5 Communication Services 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAYX icon
51
Paychex
PAYX
$40.7B
$2.03M 0.49%
26,775
+66
+0.2% +$4.57K
CME icon
52
CME Group
CME
$88.5B
$1.99M 0.48%
12,236
+159
+1% +$28.5K
AEP icon
53
American Electric Power
AEP
$71.9B
$1.97M 0.47%
24,679
-201
-0.8% -$16.4K
LMT icon
54
Lockheed Martin
LMT
$117B
$1.91M 0.46%
5,223
+273
+6% +$103K
ENTG icon
55
Entegris
ENTG
$21.1B
$1.85M 0.44%
31,318
+619
+2% +$34.4K
JNJ icon
56
Johnson & Johnson
JNJ
$609B
$1.84M 0.44%
13,101
+5,907
+82% +$861K
UNP icon
57
Union Pacific
UNP
$179B
$1.77M 0.43%
10,490
-61
-0.6% -$9.78K
AMAT icon
58
Applied Materials
AMAT
$421B
$1.77M 0.43%
+29,271
New +$1.58M
SNY icon
59
Sanofi
SNY
$107B
$1.75M 0.42%
34,270
+65
+0.2% +$3.16K
WM icon
60
Waste Management
WM
$96.1B
$1.75M 0.42%
16,485
-175
-1% -$17.7K
CRM icon
61
Salesforce
CRM
$140B
$1.62M 0.39%
8,631
+984
+13% +$166K
UNH icon
62
UnitedHealth
UNH
$387B
$1.55M 0.37%
5,244
+430
+9% +$123K
ABBV icon
63
AbbVie
ABBV
$450B
$1.52M 0.36%
15,449
+3,281
+27% +$289K
OTTR icon
64
Otter Tail
OTTR
$3.9B
$1.51M 0.36%
38,980
+59
+0.2% +$2.48K
T icon
65
AT&T
T
$152B
$1.51M 0.36%
+66,212
New +$1.51M
CCMP
66
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$1.51M 0.36%
10,829
+553
+5% +$71.6K
CVS icon
67
CVS Health
CVS
$137B
$1.49M 0.36%
22,925
+3,059
+15% +$193K
BMY icon
68
Bristol-Myers Squibb
BMY
$124B
$1.49M 0.36%
25,261
+1,704
+7% +$102K
DUK icon
69
Duke Energy
DUK
$97.5B
$1.47M 0.35%
18,396
+25
+0.1% +$2.11K
NDAQ icon
70
Nasdaq
NDAQ
$51.8B
$1.43M 0.34%
35,895
+1,215
+4% +$45.2K
AMGN icon
71
Amgen
AMGN
$198B
$1.41M 0.34%
5,981
+531
+10% +$121K
QCOM icon
72
Qualcomm
QCOM
$181B
$1.41M 0.34%
+15,404
New +$1.24M
CPT icon
73
Camden Property Trust
CPT
$11.2B
$1.4M 0.34%
15,365
+13
+0.1% +$1.15K
SPSC icon
74
SPS Commerce
SPSC
$2.41B
$1.39M 0.33%
18,448
-115
-0.6% -$7.01K
TFC icon
75
Truist Financial
TFC
$65.4B
$1.38M 0.33%
36,754

Similar funds

Stanley-Laman Group's Q2 2020 Portfolio in Review

As of Q2 2020, Stanley-Laman Group held 270 positions worth $416M, up 26% from $329M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Stanley-Laman Group's Q2 2020 filing shows 32 new, 111 increased, 38 reduced and 36 closed positions. Its largest new stake was Advanced Micro Devices: 109,759 shares worth $5.77M. The largest sale was Dover, an estimated $4.31M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

  • Stanley-Laman Group's largest Q2 2020 buy was Advanced Micro Devices: 109,759 shares worth $5.77M.
  • Stanley-Laman Group added most to Leidos in Q2 2020, an estimated $5.21M increase.
  • Stanley-Laman Group's biggest Q2 2020 reduction was Crown Castle, cutting an estimated $603K.
  • Stanley-Laman Group fully exited Dover in Q2 2020, selling an estimated $4.31M.
  • Stanley-Laman Group's ten largest holdings make up 20% of its $416M portfolio in Q2 2020.
  • Stanley-Laman Group opened 32 new positions and closed 36 in Q2 2020.
  • Stanley-Laman Group's portfolio value rose 26% quarter-over-quarter to $416M.

Based on Stanley-Laman Group's 13F filing for Q2 2020, filed 20 Jul 2020.